16-88486040-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The ENST00000319555.8(ZFPM1):c.142G>A(p.Ala48Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000211 in 1,610,890 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
ENST00000319555.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZFPM1 | NM_153813.3 | c.142G>A | p.Ala48Thr | missense_variant | 2/10 | ENST00000319555.8 | NP_722520.2 | |
ZFPM1 | XM_011522912.3 | c.280G>A | p.Ala94Thr | missense_variant | 2/10 | XP_011521214.1 | ||
ZFPM1 | XM_011522914.3 | c.241G>A | p.Ala81Thr | missense_variant | 2/10 | XP_011521216.1 | ||
ZFPM1 | XM_047433667.1 | c.189G>A | p.Ala63= | synonymous_variant | 2/9 | XP_047289623.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZFPM1 | ENST00000319555.8 | c.142G>A | p.Ala48Thr | missense_variant | 2/10 | 1 | NM_153813.3 | ENSP00000326630 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152114Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000369 AC: 9AN: 244060Hom.: 0 AF XY: 0.0000226 AC XY: 3AN XY: 132878
GnomAD4 exome AF: 0.0000158 AC: 23AN: 1458776Hom.: 0 Cov.: 32 AF XY: 0.0000124 AC XY: 9AN XY: 725618
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152114Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74312
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 14, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at